Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

[Effects of lysyl oxidase down-regulation on invasion, migration and E-cadherin protein expression of hypoxic lung cancer cells].

Wei L, Song XR, Sun JJ, Xie L, Wang XW, Lü LY.

Zhonghua Yi Xue Za Zhi. 2012 Nov 13;92(42):3004-7. doi: 10.3760/cma.j.issn.0376-2491.2012.42.015. Chinese.

PMID:
23328296
2.

Lysyl oxidase may play a critical role in hypoxia-induced NSCLC cells invasion and migration.

Wei L, Song XR, Sun JJ, Wang XW, Xie L, Lv LY.

Cancer Biother Radiopharm. 2012 Dec;27(10):672-7. doi: 10.1089/cbr.2012.1241. Epub 2012 Nov 9.

3.

[Mechanism of lysyl oxidase (LOX) in breast cancer invasion and metastasis].

Liu JL, Wei W, Tang W, Jiang Y, Yang HW, Li JT.

Zhonghua Yi Xue Za Zhi. 2012 May 29;92(20):1379-83. Chinese.

PMID:
22883193
4.

Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.

Chen LC, Tu SH, Huang CS, Chen CS, Ho CT, Lin HW, Lee CH, Chang HW, Chang CH, Wu CH, Lee WS, Ho YS.

Breast Cancer Res Treat. 2012 Aug;134(3):989-1004. doi: 10.1007/s10549-012-1986-8. Epub 2012 Mar 21.

PMID:
22434522
5.

Lysyl oxidase is associated with the epithelial-mesenchymal transition of gastric cancer cells in hypoxia.

Kasashima H, Yashiro M, Kinoshita H, Fukuoka T, Morisaki T, Masuda G, Sakurai K, Kubo N, Ohira M, Hirakawa K.

Gastric Cancer. 2016 Apr;19(2):431-42. doi: 10.1007/s10120-015-0510-3. Epub 2015 Jun 23.

PMID:
26100130
6.

Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.

Postovit LM, Abbott DE, Payne SL, Wheaton WW, Margaryan NV, Sullivan R, Jansen MK, Csiszar K, Hendrix MJ, Kirschmann DA.

J Cell Biochem. 2008 Apr 1;103(5):1369-78.

PMID:
17685448
7.

Inactivation of lysyl oxidase by β-aminopropionitrile inhibits hypoxia-induced invasion and migration of cervical cancer cells.

Yang X, Li S, Li W, Chen J, Xiao X, Wang Y, Yan G, Chen L.

Oncol Rep. 2013 Feb;29(2):541-8. doi: 10.3892/or.2012.2146. Epub 2012 Nov 19.

PMID:
23165370
8.

Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer.

Ji F, Wang Y, Qiu L, Li S, Zhu J, Liang Z, Wan Y, Di W.

Int J Oncol. 2013 May;42(5):1578-88. doi: 10.3892/ijo.2013.1878. Epub 2013 Mar 29.

9.

Reactive oxygen species promote ovarian cancer progression via the HIF-1α/LOX/E-cadherin pathway.

Wang Y, Ma J, Shen H, Wang C, Sun Y, Howell SB, Lin X.

Oncol Rep. 2014 Nov;32(5):2150-8. doi: 10.3892/or.2014.3448. Epub 2014 Aug 28.

10.

Down-regulation of GEP100 causes increase in E-cadherin levels and inhibits pancreatic cancer cell invasion.

Xie CG, Wei SM, Chen JM, Xu XF, Cai JT, Chen QY, Jia LT.

PLoS One. 2012;7(5):e37854. doi: 10.1371/journal.pone.0037854. Epub 2012 May 25.

11.

[Function of IL-18 in promoting metastasis of lung cancer].

Jiang DF, Liu WL, Lu YL, Qiu ZY, He FC.

Zhonghua Zhong Liu Za Zhi. 2003 Jul;25(4):348-52. Chinese.

PMID:
12921563
12.

[Effects of Feiyanning on the expression of epithelial-mesenchymal factors in highly metastatic lung cancer cells 95-D].

Zhao X, Wu Z, Xu Z, Wang Z, Wu J, Su W.

Zhongguo Fei Ai Za Zhi. 2011 Jun;14(6):467-71. doi: 10.3779/j.issn.1009-3419.2011.06.01. Chinese.

13.

The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1.

Schietke R, Warnecke C, Wacker I, Schödel J, Mole DR, Campean V, Amann K, Goppelt-Struebe M, Behrens J, Eckardt KU, Wiesener MS.

J Biol Chem. 2010 Feb 26;285(9):6658-69. doi: 10.1074/jbc.M109.042424. Epub 2009 Dec 21.

14.

Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H.

Ann Surg Oncol. 2009 Sep;16(9):2494-501. doi: 10.1245/s10434-009-0559-5. Epub 2009 Jun 13.

PMID:
19526206
15.

Expression of the lysyl oxidase propeptide in hepatocellular carcinoma and its clinical relevance.

Zheng Y, Wang X, Wang H, Yan W, Zhang Q, Chang X.

Oncol Rep. 2014 Apr;31(4):1669-76. doi: 10.3892/or.2014.3044. Epub 2014 Feb 20.

PMID:
24573150
16.

A molecular role for lysyl oxidase in breast cancer invasion.

Kirschmann DA, Seftor EA, Fong SF, Nieva DR, Sullivan CM, Edwards EM, Sommer P, Csiszar K, Hendrix MJ.

Cancer Res. 2002 Aug 1;62(15):4478-83.

17.

[Effect of HIF-1α and its mechanism on invasion and metastasis of esophageal carcinoma Eca109 cells in vitro and in vivo].

Jing SW, Wang YD, Zheng MM, Sun GG, Liu Q, Cheng YJ, Yang CR.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Jan;28(1):67-71. Chinese.

PMID:
22230507
18.

The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasis.

Chen WL, Kuo KT, Chou TY, Chen CL, Wang CH, Wei YH, Wang LS.

BMC Cancer. 2012 Jun 29;12:273. doi: 10.1186/1471-2407-12-273.

19.

Silencing of lysyl oxidase gene expression by RNA interference suppresses metastasis of breast cancer.

Liu JL, Wei W, Tang W, Jiang Y, Yang HW, Li JT, Zhou X.

Asian Pac J Cancer Prev. 2012;13(7):3507-11.

20.

Ionizing radiation induces tumor cell lysyl oxidase secretion.

Shen CJ, Sharma A, Vuong DV, Erler JT, Pruschy M, Broggini-Tenzer A.

BMC Cancer. 2014 Jul 22;14:532. doi: 10.1186/1471-2407-14-532.

Supplemental Content

Support Center